Ads
related to: novartis- Contact Us
Contact a PYLARIFY sales
representative to stay updated.
- Resources for PYLARIFY
Discover downloadable guides for
health care professionals.
- PYLARIFY Imaging Sites
Find or register a PYLARIFY
imaging site.
- PYLARIFY Case Studies
Review actual case study
findings for PYLARIFY.
- Contact Us
Search results
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing...
WJET - WFXP Erie· 18 hours agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
WJET - WFXP Erie· 18 hours ago...atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 2 days agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Novartis to seek approvals in two rare kidney diseases after positive Phase 3 trials
Endpoints News· 18 hours agoNovartis is building out its rare kidney disease portfolio with two batches of Phase 3 data at the...
UBS Group AG Has $167.76 Million Stock Holdings in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 5 days agoUBS Group AG trimmed its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 9.9% during the fourth quarter, according to its most recent disclosure with the Securities ...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 2 days agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
Level Four Advisory Services LLC Cuts Stock Position in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 6 days agoLevel Four Advisory Services LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 5.9% during the 4th quarter, according to the company in its most ...
Novartis Patient Information Leaked in Third-Party Data Breach at Lash Group | JD Supra
JD Supra· 2 days agoIn this notice, Lash Group explains that the incident resulted in an unauthorized party being able to access sensitive information belonging to patients enrolled in “patient support programs ...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 1 day agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
Latest 340B ruling delivers blow to providers
Healthcare Dive via Yahoo Finance· 4 days agoDrugmakers are allowed to impose conditions on which pharmacies they dispense discounted drugs to in the 340B program, according to an appellate court.
